Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection

Overview

Journal J Hepatocell Carcinoma

Date 2023 May 2

PMID 37128594

Authors

Federico Costante

Leonardo Stella

Francesco Santopaolo

Antonio Gasbarrini

Maurizio Pompili

Tarik Asselah

Francesca Romana Ponziani

Affiliations

Soon will be listed here.

Abstract

Hepatitis D virus (HDV) infection affects more than 10 million people worldwide, with an estimated prevalence of nearly 4.5% among HBsAg-positive individuals. Epidemiological studies have shown a significant increase in the prevalence of hepatocellular carcinoma (HCC) in patients with chronic HDV infection compared to those with chronic hepatitis B virus (HBV) mono-infection. Despite the clinical findings, data on molecular oncogenic mechanisms are limited and fragmentary. Moreover, the role of HDV in promoting the development of HCC has so far been controversial, because it is difficult to weigh the respective contributions of the two viruses. In this review, we focused on the direct oncogenic action of HDV, its role in modifying the tumor microenvironment, and the genetic signature of HDV-related HCC, comparing these features with HBV-related HCC.

Citing Articles

Protein regulator of cytokinesis 1 regulates autophagy in hepatitis B virus‑associated liver cancer development.

Huang J, Cheng X, Wang C, Gong F Oncol Rep. 2025; 53(3).

PMID: 39930820 PMC: 11795243. DOI: 10.3892/or.2025.8869.

Viral Hepatitis in Pregnant Mexican Women: Its Impact in Mother-Child Binomial Health and the Strategies for Its Eradication.

Garcia-Romero C, Guzman C, Martinez-Ibarra A, Cervantes A, Cerbon M Pathogens. 2024; 13(8).

PMID: 39204251 PMC: 11357198. DOI: 10.3390/pathogens13080651.

Hepatitis Delta Virus and Hepatocellular Carcinoma.

Lombardo D, Franze M, Caminiti G, Pollicino T Pathogens. 2024; 13(5).

PMID: 38787214 PMC: 11124437. DOI: 10.3390/pathogens13050362.

Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future.

Wei H, Dong C, Li X J Clin Transl Hepatol. 2024; 12(4):389-405.

PMID: 38638377 PMC: 11022065. DOI: 10.14218/JCTH.2023.00462.

The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates.

Agustiningsih A, Rasyak M, Turyadi , Jayanti S, Sukowati C Explor Target Antitumor Ther. 2024; 5(1):120-134.

PMID: 38464387 PMC: 10918233. DOI: 10.37349/etat.2024.00209.

References

Jang T, Wei Y, Liu T, Yeh M, Liu S, Hsu C . Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues. Sci Rep. 2021; 11(1):8184. PMC: 8047028. DOI: 10.1038/s41598-021-87679-w. View

Beste L, Leipertz S, Green P, Dominitz J, Ross D, Ioannou G . Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015; 149(6):1471-1482.e5. DOI: 10.1053/j.gastro.2015.07.056. View

Yu Z, Ma X, Zhang W, Chang X, An L, Niu M . Microarray Data Mining and Preliminary Bioinformatics Analysis of Hepatitis D Virus-Associated Hepatocellular Carcinoma. Biomed Res Int. 2021; 2021:1093702. PMC: 7867452. DOI: 10.1155/2021/1093702. View

He G, Karin M . NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2010; 21(1):159-68. PMC: 3193410. DOI: 10.1038/cr.2010.183. View

Sasaki K, Shindoh J, Nishioka Y, Margonis G, Sugawara T, Andreatos N . Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients. J Gastrointest Surg. 2017; 21(3):487-495. DOI: 10.1007/s11605-016-3344-3. View

Roingeard P, Dubois F, Marcellin P, Bernuau J, Bonduelle S, Benhamou J . Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection. J Med Virol. 1992; 38(3):191-4. DOI: 10.1002/jmv.1890380307. View

Collado M, Serrano M . The senescent side of tumor suppression. Cell Cycle. 2005; 4(12):1722-4. DOI: 10.4161/cc.4.12.2260. View

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu M, Allen C . The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017; 3(12):1683-1691. PMC: 5824275. DOI: 10.1001/jamaoncol.2017.3055. View

Atsama Amougou M, Noah Noah D, Moundipa P, Pineau P, Njouom R . A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa. BMC Infect Dis. 2016; 16(1):647. PMC: 5100184. DOI: 10.1186/s12879-016-1992-2. View

10.

ANTHONY P . Hepatocellular carcinoma: an overview. Histopathology. 2001; 39(2):109-18. DOI: 10.1046/j.1365-2559.2001.01188.x. View

11.

Wen Y, Golubkov V, Strongin A, Jiang W, Reed J . Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation. J Biol Chem. 2007; 283(5):2793-803. DOI: 10.1074/jbc.M708419200. View

12.

Sartorius K, An P, Winkler C, Chuturgoon A, Li X, Makarova J . The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Front Immunol. 2021; 12:661204. PMC: 8117219. DOI: 10.3389/fimmu.2021.661204. View

13.

Romeo R, Petruzziello A, Pecheur E, Facchetti F, Perbellini R, Galmozzi E . Hepatitis delta virus and hepatocellular carcinoma: an update. Epidemiol Infect. 2018; 146(13):1612-1618. PMC: 9507952. DOI: 10.1017/S0950268818001942. View

14.

An Y, Gao S, Zhao W, Qiu B, Xia N, Zhang P . Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol. 2018; 24(25):2733-2740. PMC: 6034152. DOI: 10.3748/wjg.v24.i25.2733. View

15.

Clippinger A, Bouchard M . Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential. J Virol. 2008; 82(14):6798-811. PMC: 2446973. DOI: 10.1128/JVI.00154-08. View

16.

Russo F, Zanetto A, Pinto E, Battistella S, Penzo B, Burra P . Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?. Int J Mol Sci. 2022; 23(1). PMC: 8745141. DOI: 10.3390/ijms23010500. View

17.

Cross T, Rizzi P, Horner M, Jolly A, Hussain M, Smith H . The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2007; 80(2):277-82. DOI: 10.1002/jmv.21078. View

18.

Saracco G, Rosina F, Brunetto M, Amoroso P, Caredda F, Farci P . Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol. 1987; 5(3):274-81. DOI: 10.1016/s0168-8278(87)80032-6. View

19.

Yang P, Li Q, Feng Y, Zhang Y, Markowitz G, Ning S . TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell. 2012; 22(3):291-303. PMC: 3443566. DOI: 10.1016/j.ccr.2012.07.023. View

20.

Taylor J . Hepatitis delta virus. Virology. 2005; 344(1):71-6. DOI: 10.1016/j.virol.2005.09.033. View